Spanish Red Biotech Pipeline

MSD

CAVATAK/Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: V937 in Combination with Pembrolizumab Versus Pembrolizumab Alone in Participants with Advanced/Metastatic Melanoma
Phase: 2Phase II in Spain, 1Phase I